Combination therapy with potent PI3K and MAPK inhibitors overcomes adaptive kinome resistance to single agents in preclinical models of glioblastomaRobert S. McNeill, C. Ryan Miller, Demitra A. Canoutas et al.|Neuro-Oncology|2017Cited by 63
Cooperativity between H3.3K27M and PDGFRA poses multiple therapeutic vulnerabilities in human iPSC-derived diffuse midline glioma avatarsKasey Skinner, Frank B. Furnari, Florina Grigore et al.|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 3